» Articles » PMID: 31644544

The Impact on the Bioenergetic Status and Oxidative-mediated Tissue Injury of a Combined Protocol of Hypothermic and Normothermic Machine Perfusion Using an Acellular Haemoglobin-based Oxygen Carrier: The Cold-to-warm Machine Perfusion of the Liver

Overview
Journal PLoS One
Date 2019 Oct 24
PMID 31644544
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: The combination of hypothermic and normothermic machine perfusion (HMP+NMP) of the liver provides individual benefits of both techniques, improving the rescue of marginal organs. The aim of this study was to investigate the effect on the bioenergetic status and the oxidative-mediated tissue injury of an uninterrupted combined protocol of HMP+NMP using a single haemoglobin-based oxygen carrier (HBOC)-based perfusate.

Methods: Ten discarded human donor livers had either 2 hours of dual hypothermic oxygenated perfusion (D-HOPE) with sequential controlled rewarming (COR) and then NMP using the HBOC-based perfusate uninterruptedly (cold-to-warm group); or 2 hours of hypothermic oxygenated perfusion (HOPE) with an oxygen carrier-free perfusate, followed by perfusate exchange and then NMP with an HBOC-based perfusate. Markers of liver function, tissue adenosine triphosphate (ATP) levels and tissue injury were systematically assessed.

Results: The hypothermic phase downregulated mitochondrial respiration and increased ATP levels in both groups. The cold-to-warm group presented higher arterial vascular resistance during rewarming/NMP (p = 0.03) with a trend of lower arterial flow (p = 0.09). At the end of NMP tissue expression of markers of reactive oxygen species production, oxidative injury and inflammation were comparable between the groups.

Conclusion: The uninterrupted combined protocol of HMP+NMP using an HBOC-based perfusate-cold-to-warm MP-mitigated the oxidative-mediated tissue injury and enhanced hepatic energy stores, similarly to an interrupted combined protocol; however, it simplified the logistics of this combination and may favour its clinical applicability.

Citing Articles

Cost-effectiveness of Dual Hypothermic Oxygenated Machine Perfusion Versus Static Cold Storage in DCD Liver Transplantation.

Endo C, van Rijn R, Huurman V, Schurink I, van den Berg A, Murad S Transplantation. 2025; 109(2):e101-e108.

PMID: 39853733 PMC: 11745596. DOI: 10.1097/TP.0000000000005232.


Hemoglobin-based oxygen carriers: Clinical application of HBOC-201 as an alternative to red blood cells for machine perfusion in liver transplantation.

Moein M, Ahmed M, Arafa F, Saidi R Surg Pract Sci. 2025; 10():100120.

PMID: 39845585 PMC: 11749418. DOI: 10.1016/j.sipas.2022.100120.


A reproducible extended ex-vivo normothermic machine liver perfusion protocol utilising improved nutrition and targeted vascular flows.

Clarke G, Mao J, Hann A, Fan Y, Gupta A, Nutu A Commun Med (Lond). 2024; 4(1):214.

PMID: 39448795 PMC: 11502869. DOI: 10.1038/s43856-024-00636-2.


Twelve-hour normothermic liver perfusion in a rat model: characterization of the changes in the ex-situ bio-molecular phenotype and metabolism.

Dondossola D, Lonati C, Battistin M, Vivona L, Zanella A, Maggioni M Sci Rep. 2024; 14(1):6040.

PMID: 38472309 PMC: 10933381. DOI: 10.1038/s41598-024-56433-3.


Gene Therapy in Organ Transplantation: Considerations and Clinical Translation.

Mendiola Pla M, Bowles D Hum Gene Ther. 2023; 35(7-8):284-297.

PMID: 38131288 PMC: 11044854. DOI: 10.1089/hum.2023.193.


References
1.
Ninomiya M, Shirabe K, Shimada M, Terashi T, Maehara Y . Role of UCP2 expression after hepatic warm ischemia-reperfusion in the rat. Gut Liver. 2011; 5(4):486-92. PMC: 3240793. DOI: 10.5009/gnl.2011.5.4.486. View

2.
Boteon Y, Laing R, Schlegel A, Wallace L, Smith A, Attard J . Combined Hypothermic and Normothermic Machine Perfusion Improves Functional Recovery of Extended Criteria Donor Livers. Liver Transpl. 2018; 24(12):1699-1715. PMC: 6588092. DOI: 10.1002/lt.25315. View

3.
Fontes P, Lopez R, van der Plaats A, Vodovotz Y, Minervini M, Scott V . Liver preservation with machine perfusion and a newly developed cell-free oxygen carrier solution under subnormothermic conditions. Am J Transplant. 2015; 15(2):381-94. PMC: 5024042. DOI: 10.1111/ajt.12991. View

4.
Watson C, Jochmans I . From "Gut Feeling" to Objectivity: Machine Preservation of the Liver as a Tool to Assess Organ Viability. Curr Transplant Rep. 2018; 5(1):72-81. PMC: 5843692. DOI: 10.1007/s40472-018-0178-9. View

5.
Watson C, Kosmoliaptsis V, Pley C, Randle L, Fear C, Crick K . Observations on the ex situ perfusion of livers for transplantation. Am J Transplant. 2018; 18(8):2005-2020. PMC: 6099221. DOI: 10.1111/ajt.14687. View